Ocera Therapeutics fka OCRX

[king oil]

ok thanks. I'll check into it and perhaps do something similar. I can't help wonder though if perhaps we're missing something? why wouldn't institutions and more investors be purchasing shares before the acquisition closes? The share price is a huge discount vs. potential payments. It's as if the market is only giving a 25% chance of the first couple milestones being achieved.